Essential Eye Cancer Podcast

Dr. Paul Finger, MD
  • 5.0(5개의 평가)
  • 건강 및 피트니스
Essential Eye Cancer Podcast

Welcome to the Essential Eye Cancer Podcast with Dr. Paul Finger. Dr. Finger is an internationally recognized eye cancer specialist offering excellence in ophthalmic oncology care. He is Director of The New York Eye Cancer Center and author of the web site eyecancer.com. He has authored over 300 scientific articles, invented new methods for eye cancer diagnosis and treatment and always strives for excellence in his patient’s care. The following PodCast is presented to teach you about a unique aspect of eye cancer care. This information reflects Dr. Fingers' research, teaching, and experience caring for patients over the last 35 years.

  1. Conjunctival Tumors Overview

    2020. 10. 26.

    Conjunctival Tumors Overview

    Tumors and cancers commonly occur on the conjunctiva and often grow onto the corneal surface. Both conjunctival melanoma and squamous carcinoma have been associated with sun (ultraviolet UV-ray) exposure, so Dr. Finger says, "Think of Sunglasses as Sunblock for your Eyes.®" Commonly treated with observation for growth, surgical removal or a combination of surgery and freezing "cryotherapy," over the last 10 years more and more patients are treated with immunotherapy or chemotherapy eye drops. Of course, your doctor may need to biopsy first, but at The New York Eye Cancer Center, most patients don't need extensive surgery.    Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170

    17분
  2. Large Clinical Trials Won't Change Physics

    2020. 10. 05.

    Large Clinical Trials Won't Change Physics

    This Podcast takes a closer look at what I do to maximize eye radiation outcomes and minimize patient risk. Until we have a treatment for metastatic ocular melanoma, destruction of the intraocular tumor will be the best way to prevent and thus "treat" metastasis.  Across the world, each eye cancer center has its own radiation methods to destroy choroidal melanomas. However, a closer look at the methods of plaque selection and implementation reveals significant differences. This Podcast discusses basic plaque design, construction, and dose calculations. I explain why certain methods/plaques are more likely to result in eye cancer control. This Podcast is targeted to help eye cancer specialists improve their results. Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170

    13분
  3. Super-Thick Amniotic Membrane Grafts

    2020. 09. 28.

    Super-Thick Amniotic Membrane Grafts

    This Podcase discusses a technique I introduced to ophthalmic oncology. Sometimes, when eye cancer specialists have to remove a large tumor from the surface of the eye, we created a large tissue-defect on its surface. The surgeon cannot leave it grow on its own because the eyelid can scar and stick to the eyeball (called symblepharon). This scarring can hamper the movement of the eye and doesn't look normal. So, decades ago, I used to borrow some mucus membrane tissue from the inside of the cheek (mouth). This was a second surgery that left the patient's mouth sore and swollen for a week or two. Thankfully, super-thick amniotic membranes became commercially available. These large thick pieces of donor amniotic membrane were easily sewn into place and helped the eye heal without symblepharon scarring. This PodCast describes my technique of Super-thick amniotic membrane grafting for ocular surface reconstruction. Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170

    8분
  4. Iris Tumors

    2020. 09. 14.

    Iris Tumors

    Iris tumors are visible. Patients see them in the mirror and eye care specialists view them through the clear cornea. We use specialized ultrasound (UBM) and anterior segment OCT tests to reveal the contents, distribution, and size of these tumors. Most are benign and thus can be observed for growth prior to intervention. Others are either clinically diagnosed and treated or undergo biopsy. We review the differences between biopsy methods. In this Podcast, we will explore iris tumors, their diagnosis, and treatment. Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170

    16분
  5. Partial Sclerouvectomy PSLU Endoresection or Surgical Removal for Uveal Melanoma

    2020. 08. 31.

    Partial Sclerouvectomy PSLU Endoresection or Surgical Removal for Uveal Melanoma

    Cancer textbooks tell us to remove or destroy primary cancers to prevent spread (metastasis) to other parts of the body. In the 1950s, most eyes with choroidal melanoma were removed. Some small anterior choroidal, ciliary body and iris melanomas were locally resected. However, The multicenter, international, Collaborative Ocular Melanoma Study taught us that removal of the eye was not necessary for moderately sized choroidal melanomas. That eye and vision sparing plaque radiation therapy was statistically equivalent for the prevention of metastatic disease. However, surgical removal, including local resection names PLSU or partial lamellar sclerouvectomy continued to be used around the world. Meanwhile, others expanded the use of plaque radiation to anterior uveal, ciliary body and iris melanomas. This PodCast compares and contrasts resection versus plaque therapy for treatment of anterior uveal melanoma. Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170

    13분
  6. Vascular Tumors within the Eye

    2020. 08. 24.

    Vascular Tumors within the Eye

    There are many different types of vascular tumors within the eye. In the uvea or vascular layer beneath the retina, there occur both circumscribed and diffuse hemangiomas. The latter or diffuse variant is commonly associated with the congenital neurologic disorder Sturge-Weber Syndrome (encephalotrigeminal angiomatosis). It is associated with Port-Wine skin coloration, glaucoma, seizures, intellectual disability, and ipsilateral leptomeningeal angiomas. Within the eye, both circumscribed and diffuse hemangiomas may leak causing secondary retinal detachments. Vision changes can also be due to physical displacement of the retina, cystoid retinopathy, and secondary glaucoma. Vascular tumors also occur in the retina. These include capillary hemangioma with or without Von Hippel-Landau Syndrome, cavernous retinal hemangioma, and Racemose hemangioma. Though none of these tumors spread to other parts of the body, each can be differentiated by clinical characteristics and methods of management discussed in this Podcast. Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170

    12분
  7. Basic Eyelid Tumors II Treatment Overview

    2020. 08. 10.

    Basic Eyelid Tumors II Treatment Overview

    Tumors and cancers commonly occur on the eyelids. Once the clinical or pathologic diagnosis is established it is time to consider treatment. Eye cancer specialists will recommend either removal or destruction of the eyelid cancer. Depending on the type, size, and location of the tumor, different surgical or treatment strategies will be used. These treatments can range from simple surgical excision of the tumor and margins or Moh's microsurgical resection, typically followed by oculoplastic surgical repair. When tumors invade around the eye, into the orbit, brain, or sinuses, treatment becomes more complex. In these cases, orbitotomy, exenteration, radiation, and even chemotherapy may be needed. Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170

    6분
  8. Basic Eyelid Tumors Diagnostic Overview

    2020. 08. 03.

    Basic Eyelid Tumors Diagnostic Overview

    Tumors and cancers commonly occur on the eyelids. Most have been associated with sun (ultraviolet UV-ray) exposure. The most common eyelid cancer is basal cell carcinoma, but squamous carcinoma, sebaceous carcinoma, and melanoma can occur. If the tumor doesn't have a classic, diagnostic appearance, a small biopsy for pathology evaluation may be needed. This podcast describes the clinical characteristics of these tumors, how they grow, and even spread to other parts of the body. Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170

    8분
모두 보기(36개)

평가 및 리뷰

5
최고 5점
5개의 평가

소개

Welcome to the Essential Eye Cancer Podcast with Dr. Paul Finger. Dr. Finger is an internationally recognized eye cancer specialist offering excellence in ophthalmic oncology care. He is Director of The New York Eye Cancer Center and author of the web site eyecancer.com. He has authored over 300 scientific articles, invented new methods for eye cancer diagnosis and treatment and always strives for excellence in his patient’s care. The following PodCast is presented to teach you about a unique aspect of eye cancer care. This information reflects Dr. Fingers' research, teaching, and experience caring for patients over the last 35 years.

정보

  • 제작진
    Dr. Paul Finger, MD
  • 방송 연도
    2020년
  • 에피소드
    36
  • 등급
    전체 연령 사용가
  • 저작권
    © 2020
  • 웹사이트 보기
    Essential Eye Cancer Podcast

무삭제판 에피소드를 청취하려면 로그인하십시오.

이 프로그램의 최신 정보 받기

프로그램을 팔로우하고, 에피소드를 저장하고, 최신 소식을 받아보려면 로그인하거나 가입하십시오.
국가 또는 지역 선택

아프리카, 중동 및 인도

아시아 태평양

유럽

라틴 아메리카 및 카리브해

미국 및 캐나다